| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-06 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |